Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy

Sherief Abd-Elsalam100 enrolled

Overview

propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy

Effect of use of propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy, Randomised controlled trial.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

100

Conditions

Cirrhosis, Liver

Interventions

MidazolamDRUG

Midazolam 3 mg i.v added to fentanyl 0.5 ug/kg till reaching satisfactory level of sedation

PropofolDRUG

Propofol 1 mg/kg i.v added to fentanyl 0.5 ug/kg i.v till reaching satisfactory level of sedation

Eligibility

Sex: ALLMin age: 45 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Liver cirrhosis * presented to colonoscopy Exclusion Criteria: * Encephalopathy * Hypersensitivity * Coagulopathy

Locations (1)

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Outcomes

Primary Outcomes

Number of patients adequately sedated

The number of patients adequately sedated

Time frame: 6 months

Central Contacts

Sherief Abd-Elsalam, MD

CONTACT

00201095159522 sheriefabdelsalam@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.